Trifluoperazine manufacturers & suppliers

Trifluoperazine

Form: Tablets

Strength: 1 mg, 2 mg, 5 mg, 10 mg

Reference Brands: Stelazine®(US)

Category: Antipsychotropic Drugs

Trifluoperazine is a typical antipsychotic from the phenothiazine class, primarily used to manage schizophrenia and severe anxiety. Available in tablet forms of 1 mg to 10 mg, it may also be found in injectable formulations in select EU markets. Though Stelazine® was a popular brand in the US, it is now primarily offered as a generic by companies such as Mylan and Sandoz. In the EU, Trifluoperazine is distributed under regional generic names. For global pharma buyers, B2B platforms offer reliable sourcing of GMP-compliant Trifluoperazine, ensuring consistent quality and regulatory adherence for neuropsychiatric treatment programs and institutional supply chains.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Risperidone Long-Acting Injection

Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes

Form: Long-Acting Injection

Reference Brands: Risperdal Consta(US &EU)

View Details
Zuclopenthixol Ong-Acting Im Injection (Depot)

Strength: 200 mg/mL, 500 mg/mL

Form: Long-acting IM Injection (Depot)

Reference Brands: Clopixol Depot®(US)

View Details
Zuclopenthixol Short-Acting Intramuscular Injection

Strength: 50 mg/mL

Form: Short-acting Intramuscular Injection

Reference Brands: Clopixol-Acuphase®

View Details
Zuclopenthixol Tablets

Strength: 10 mg, 25 mg, 40 mg

Form: Oral Tablets

Reference Brands: Clopixol®(EU)

View Details

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.